The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer

Metastatic breast cancer is refractory to conventional therapies and is an end-stage disease. RUNX2 is a transcription factor that becomes oncogenic when aberrantly expressed in multiple tumor types, including breast cancer, supporting tumor progression and metastases. Our previous work demonstrated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Horm Cancer
Main Authors: Bolf, Eric L., Gillis, Noelle E., Barnum, Michael S., Beaudet, Caitlin M., Yu, Grace Y., Tomczak, Jennifer A., Stein, Janet L., Lian, Jane B., Stein, Gary S., Carr, Frances E.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2019
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007220/
https://ncbi.nlm.nih.gov/pubmed/31865591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-019-00373-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados